Duke Cancer Center /ID# 129356 — Durham, North Carolina

Duke Cancer Center /ID# 129356 is a clinical research site located in Durham, North Carolina, United States 27710-3000.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Center /ID# 129356 has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center /ID# 129356?

Duke Cancer Center /ID# 129356 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center /ID# 129356 conducted?

Duke Cancer Center /ID# 129356 has 1 clinical trials on record. Their work covers Relapsed/Refractory Multiple Myeloma.

Is Duke Cancer Center /ID# 129356 accredited by Crixeo Health?

Duke Cancer Center /ID# 129356 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Center /ID# 129356?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.